EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS). The HIFU division develops, manufactures, and markets devices for the minimally invasive destruction of various types of localized tumors using HIFU technology.
Read More…
Industry, Sector and Symbol
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Phone33-04-72-15-31-50
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$46.17 million
Profitability
Miscellaneous
Employees215
Next Earnings Date8/29/2019 (Confirmed)
OptionableOptionable
Edap Tms (NASDAQ:EDAP) Frequently Asked Questions
What is Edap Tms' stock symbol?
Edap Tms trades on the NASDAQ under the ticker symbol "EDAP."
How were Edap Tms' earnings last quarter?
Edap Tms SA (NASDAQ:EDAP) posted its earnings results on Wednesday, November, 14th. The medical equipment provider reported ($0.02) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.02). The medical equipment provider had revenue of $9.47 million for the quarter, compared to analysts' expectations of $10.34 million. Edap Tms had a negative return on equity of 1.13% and a negative net margin of 0.36%. View Edap Tms' Earnings History.
When is Edap Tms' next earnings date?
What price target have analysts set for EDAP?
1 analysts have issued 12 month price objectives for Edap Tms' shares. Their forecasts range from $7.00 to $7.00. On average, they expect Edap Tms' stock price to reach $7.00 in the next twelve months. This suggests a possible upside of 115.4% from the stock's current price. View Analyst Price Targets for Edap Tms.
What is the consensus analysts' recommendation for Edap Tms?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Edap Tms in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Edap Tms.
Has Edap Tms been receiving favorable news coverage?
Headlines about EDAP stock have trended positive recently, according to InfoTrie. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Edap Tms earned a daily sentiment score of 2.5 on InfoTrie's scale. They also assigned news articles about the medical equipment provider a news buzz of 6.0 out of 10, meaning that recent press coverage is somewhat likely to have an impact on the company's share price in the next several days. View News Stories for Edap Tms.
Are investors shorting Edap Tms?
Edap Tms saw a increase in short interest in the month of July. As of July 31st, there was short interest totalling 102,900 shares, an increase of 21.6% from the June 30th total of 84,600 shares. Based on an average daily volume of 174,200 shares, the short-interest ratio is currently 0.6 days. Currently, 0.4% of the company's stock are sold short. View Edap Tms' Current Options Chain.
Who are some of Edap Tms' key competitors?
Some companies that are related to Edap Tms include Zynex (ZYXI), Semler Scientific (SMLR), Stereotaxis (STXS), Fonar (FONR), Rockwell Medical (RMTI), BioSig Technologies (BSGM), Fc Global Realty (FCRE), Second Sight Medical Products (EYES), Soleno Therapeutics (SLNO), electroCore (ECOR), Helius Medical Technologies (HSDT), IRIDEX (IRIX), Precision Optics (PEYE), Digirad (DRAD) and ENDRA Life Sciences (NDRA).
What other stocks do shareholders of Edap Tms own?
Who are Edap Tms' key executives?
Edap Tms' management team includes the folowing people:
- Mr. Marc Oczachowski, CEO & Exec. Director (Age 49)
- Mr. Franois Dietsch, Chief Financial Officer (Age 43)
- Ms. Blandine Confort, Investor Relations Officer and Sec.
Who are Edap Tms' major shareholders?
Edap Tms' stock is owned by many different of institutional and retail investors. Top institutional investors include Fosun International Ltd (1.37%), Morgan Stanley (0.92%), Acadian Asset Management LLC (0.78%), Susquehanna International Group LLP (0.71%) and JPMorgan Chase & Co. (0.34%).
Which institutional investors are buying Edap Tms stock?
EDAP stock was acquired by a variety of institutional investors in the last quarter, including Acadian Asset Management LLC, Morgan Stanley, Susquehanna International Group LLP, JPMorgan Chase & Co. and Fosun International Ltd.
How do I buy shares of Edap Tms?
Shares of EDAP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Edap Tms' stock price today?
One share of EDAP stock can currently be purchased for approximately $3.25.
How big of a company is Edap Tms?
Edap Tms has a market capitalization of $94.25 million and generates $46.17 million in revenue each year. The medical equipment provider earns $-400,000.00 in net income (profit) each year or $0.02 on an earnings per share basis. Edap Tms employs 215 workers across the globe.View Additional Information About Edap Tms.
What is Edap Tms' official website?
How can I contact Edap Tms?
Edap Tms' mailing address is Parc d'Activites la Poudrette-Lamartine 4/6 rue du Dauphine, Vaulx-en-Velin I0, 69120. The medical equipment provider can be reached via phone at 33-04-72-15-31-50 or via email at [email protected]
MarketBeat Community Rating for Edap Tms (NASDAQ EDAP)
MarketBeat's community ratings are surveys of what our community members think about Edap Tms and other stocks. Vote "Outperform" if you believe EDAP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EDAP will underperform the S&P 500 over the long term. You may vote once every thirty days.
